Clinical Trials

NCT Number: NCT05869682 Phase: PHASE2 Trial Summary: This phase II trial tests how well bright white light (BWL) therapy works in reducing cancer-related fatigue and depression in patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant pa – clinicaltrials.gov for more information and locations […]

NCT Number: NCT04346225 Phase: Phase 2 Trial Summary: This is a prospective imaging study evaluating the utility of baseline metabolic MR imaging as a diagnostic and response monitoring tool in patients with advanced prostate cancer. – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Rahul Aggarwal Acronym:

NCT Number: NCT05045066 Phase: Early Phase 1 Trial Summary: This early phase I is to find out how common vitamin D deficiency is among African American patients with a history of prostate cancer that has not spread to other parts of the bod – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Mayo Clinic […]

NCT Number: NCT04331535 Phase: Not Applicable Trial Summary: This trial will determine the clinical effectiveness of polygenic risk score testing among patients at high genetic risk for at least one of six diseases (coronary artery disease, – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Boston VA Research Institute, Inc. Acronym: GenoVA

NCT Number: NCT04585750 Phase: Phase 1|Phase 2 Trial Summary: This study will assess the safety, tolerability, and efficacy of multiple dose levels of PC14586 alone and in combination with pembrolizumab in participants with advanced solid tumors containing a TP5 – clinicaltrials.gov for more information and locations and locations Clinicaltrials.gov Trial Sponsor(s): PMV Pharmaceuticals, Inc Acronym:

NCT Number: NCT05010200 Phase: Phase 1 Trial Summary: This proof of concept study is designed to test the safety and tolerability of PGV001-based personalized multi-peptide vaccines in combination with CDX-301 in subjects with a histo – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Ashutosh Kumar Tewari Acronym: PGV-Prostate

NCT Number: NCT05225428 Phase: Not Applicable Trial Summary: The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Dana-Farber Cancer Institute Acronym: VERDI

NCT Number: NCT05471414 Phase: Not Applicable Trial Summary: The study is comparing the effect on weight of providing home-delivered whole-food, plant-based meals versus standard, general nutritional counseling to men with prostate cancer on androgen-deprivatio – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Weill Medical College of Cornell University Acronym: WFPBD

NCT Number: NCT05754658 Phase: Trial Summary: he goal of this study is to develop a comprehensive characterization of genetic and molecular drivers of breast and prostate cancer in individuals of – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Fox Chase Cancer Center Acronym:

NCT Number: NCT05367440 Phase: Phase 1|Phase 2 Trial Summary: This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents ( – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): AstraZeneca Acronym: PETRANHA